ProMIS Neurosciences is trading at $4.41, up 6.01% in pre-market, with no company-specific announcement clearly explaining the rise.
- Latest listed news: a November 5 announcement that ProMIS will participate in Guggenheim's November 9–11 conference; its fireside chat is set for November 10.
- The company will report third-quarter results and provide a business update on November 12.
- The move follows several sessions of gains, but available evidence does not establish a catalyst or link it to broader market sentiment.